differences in glp 1 drugs GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Drug Comparison in Diabetes

[DOI] [PubMed] [Google Scholar] 7.Nauck MA, et al

Avoid weight/obesity bias in deciding who should discontinue GLP-1RA therapy

Aetna's standard 2026 commercial formulary generally includes: Wegovy (semaglutide 2.4 mg) for chronic weight management Saxenda (liraglutide 3.0 mg) for chronic weight management Ozempic (semaglutide 1.0 mg / 2.0 mg) for type 2 diabetes only Mounjaro (tirzepatide) for type 2 diabetes only Zepbound (tirzepatide) for chronic weight management, on select plans Keep in mind that formulary placement affects your copay

This is particularly important, considering that Pfizer NYSE: PFE recently discontinued its oral GLP-1 treatment because of these issues

The Saxagliptin Assessment of Vascular Outcomes (SAVOR-TIMI 53) study is a similar study in 12,000 patients comparing saxagliptin with placebo in diabetic patients with high cardiovascular risk